Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-1,075
Closed -$212K – 160
2023
Q4
$212K Buy
+1,075
New +$190K 0.13% 141
2023
Q3
– Sell
-1,338
Closed -$230K – 154
2023
Q2
$230K Sell
1,338
-78
-6% -$13.5K 0.16% 134
2023
Q1
$236K Sell
1,416
-27
-2% -$4.42K 0.17% 139
2022
Q4
$211K Buy
1,443
+87
+6% +$12.9K 0.17% 142
2022
Q3
$201K Buy
1,356
+9
+0.7% +$1.5K 0.19% 125
2022
Q2
$232K Buy
1,347
+33
+3% +$5.71K 0.23% 105
2022
Q1
$248K Sell
1,314
-284
-18% -$56.1K 0.22% 117
2021
Q4
$390K Buy
+1,598
New +$350K 0.38% 76

Other funds holding ZTS

CEDRUS's ZTS Position: Q1 2024 in Review

CEDRUS sold out of Zoetis (ZTS) in Q1 2024, closing a stake of 1,075 shares — an estimated $212K sold.

CEDRUS first reported a position in ZTS in Q4 2021 and held it in 8 quarters. The position peaked at $390K in Q4 2021. 1,742 funds tracked by Wall St. Rank hold ZTS as of Q1 2024.

  • CEDRUS reported no remaining Zoetis position as of Q1 2024 after selling out during the quarter.
  • CEDRUS sold 1,075 Zoetis shares in Q1 2024, an estimated $212K.
  • CEDRUS first reported a position in Zoetis in Q4 2021 and held it in 8 quarters.
  • CEDRUS's Zoetis position peaked at $390K in Q4 2021.
  • 1,742 funds tracked by Wall St. Rank held Zoetis as of Q1 2024.

Based on CEDRUS's 13F filing for Q1 2024, filed 15 Apr 2024.